CHRISTIAN WAAGE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

HERON THERAPEUTICS, INC. /DE/

Filing Date Source Excerpt
2017-04-26 Christian Waage has served as a director of Heron since June 2016. ... The Audit Committee is composed of three directors: Messrs. Johnson, Poyhonen and Waage. Mr. Waage was appointed to the Audit Committee in June 2016. ... The Nominating and Corporate Governance Committee (the Governance Committee) is composed of three directors: Messrs. Tang, Johnson and Waage. Mr. Waage was appointed to the Governance Committee in April 2017. ... The following table includes compensation for services provided by our non-employee directors for the year ended December 31, 2016: ... Mr. Waage was appointed to the board in June 2016. The amount included in Fees Earned represents the prorated annual retainer for 2016 services as a director.
2018-04-30 Christian Waage has served as a director of Heron since 2016. ... The Audit Committee is composed of three directors: Messrs. Johnson, Poyhonen and Waage. ... The Governance Committee is composed of three directors: Messrs. Tang, Johnson and Waage. ... The following table includes compensation for services provided by our non-employee directors for the year ended December 31, 2017: Fees Earned: $50,000, Option Awards: $185,261, Total: $235,261.
2019-04-26 Christian Waage has served as a director of Heron since 2016. ... The Audit Committee is composed of three directors: Messrs. Johnson, Poyhonen and Waage. ... The Governance Committee is composed of three directors: Messrs. Tang, Johnson and Waage. ... The following table includes compensation for services provided by our non-employee directors for the year ended December 31, 2018: Christian Waage total compensation $305,481.
2020-04-23 Christian Waage has served as a director of Heron since 2016. ... The Audit Committee is composed of three directors: Messrs. Davis, Johnson and Waage. ... The Governance Committee is composed of three directors: Messrs. Johnson, Tang and Waage. ... The following table includes compensation for services provided by our non-employee directors for the year ended December 31, 2019: ... Option Awards: $247,795 Fees Earned or Paid in Cash: $50,000 Total: $297,795.
2021-04-22 Christian Waage has served as a director of Heron since 2016. Mr. Waage has more than 20 years of regulatory, legal and financial transaction experience primarily in the biotechnology industry.
2022-04-25 Christian Waage has served as a director of Heron since 2016. The Board has concluded that Mr. Waage should serve as a director based on his experience in regulatory, legal and finance matters.
2023-05-01 Christian Waage has served as a director of Heron since 2016. The Compensation Committee is composed of three directors: Messrs. Kotler and Waage and Ms. Rodriguez. Mr. Waage serves as the Chair of the Governance Committee. ... The following table includes compensation for services provided by our non-employee directors for the year ended December 31, 2022: ... Christian Waage $77,500 Fees Earned or Paid in Cash, $105,709 Stock Awards, $126,018 Option Awards, $309,227 Total.
2024-04-29 Christian Waage has served as a director of Heron since 2016. Mr. Waage has more than 15 years of regulatory, legal and financial transaction experience, primarily in the biotechnology industry. Since 2017, he has served as Executive Vice President and General Counsel of Gossamer Bio, Inc., a publicly traded biotechnology company. From 2013 to 2016, Mr. Waage held various positions at Receptos, Inc., a wholly owned subsidiary of Celgene Corporation, most recently serving as Managing Director. Prior to its acquisition by Celgene Corporation in 2015, he served as Senior Vice President and General Counsel of Receptos, Inc. From 2012 through its acquisition by Vista Equity Partners Management, LLC in 2013, Mr. Waage served as Vice President, General Counsel and Corporate Secretary at Websense, Inc. From 2008 through its acquisition by AstraZeneca PLC in 2012, he served as Vice President, General Counsel and Corporate Secretary of Ardea Biosciences, Inc. Prior to 2008, Mr. Waage served as a partner at DLA Piper LLP. He received a J.D. from the University of San Diego School of Law and a B.A. degree in economics from the University of California, San Diego. The Board has concluded that Mr. Waage should serve as a director based on his experience in regulatory, legal and finance matters.

Data sourced from SEC filings. Last updated: 2025-12-06